Compare ARMP & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARMP | BYND |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | United States |
| Employees | 61 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.5M | 269.7M |
| IPO Year | 1996 | 2018 |
| Metric | ARMP | BYND |
|---|---|---|
| Price | $8.06 | $0.77 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 2 | 7 |
| Target Price | ★ $15.00 | $0.83 |
| AVG Volume (30 Days) | 73.3K | ★ 84.1M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.69 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $275,496,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.74 | $0.50 |
| 52 Week High | $14.98 | $7.69 |
| Indicator | ARMP | BYND |
|---|---|---|
| Relative Strength Index (RSI) | 37.57 | 46.38 |
| Support Level | $7.43 | $0.67 |
| Resistance Level | $12.11 | $0.82 |
| Average True Range (ATR) | 1.12 | 0.08 |
| MACD | -0.22 | -0.02 |
| Stochastic Oscillator | 14.20 | 11.11 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.